Rainbow Children's Medicare Limited (BOM:543524)
India · Delayed Price · Currency is INR 1,184.95
-30.80 (-2.53%)
At close: Feb 13, 2026
BOM:543524 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 16,133 | 15,159 | 12,969 | 11,736 | 9,738 | 6,500 |
Revenue Growth (YoY) | 8.50% | 16.88% | 10.51% | 20.52% | 49.80% | -9.64% |
Cost of Revenue | 4,746 | 4,341 | 3,662 | 3,300 | 3,298 | 2,256 |
Gross Profit | 11,387 | 10,818 | 9,307 | 8,436 | 6,440 | 4,245 |
Selling, General & Admin | 4,338 | 4,022 | 3,360 | 3,009 | 2,267 | 119.44 |
Other Operating Expenses | 1,905 | 1,895 | 1,629 | 1,423 | 1,123 | 2,494 |
Operating Expenses | 7,682 | 7,303 | 6,110 | 5,343 | 4,223 | 3,350 |
Operating Income | 3,704 | 3,515 | 3,197 | 3,092 | 2,217 | 894.96 |
Interest Expense | -752.43 | -724.55 | -590.54 | -545.71 | -529.27 | -432.44 |
Interest & Investment Income | 226.47 | 226.47 | 279.83 | 302.09 | 122.95 | 93.05 |
Currency Exchange Gain (Loss) | -0.14 | -0.14 | -0.23 | -1.36 | 0.05 | 0.22 |
Other Non Operating Income (Expenses) | 22.54 | 0.11 | 0.05 | -6.23 | -2.76 | -3.42 |
EBT Excluding Unusual Items | 3,201 | 3,017 | 2,886 | 2,841 | 1,808 | 552.37 |
Impairment of Goodwill | - | - | - | -29.87 | - | - |
Gain (Loss) on Sale of Investments | 281.02 | 281.02 | 58.85 | 5.43 | 11.56 | 0.17 |
Gain (Loss) on Sale of Assets | 0.8 | 0.8 | 1.27 | 0.36 | -0.92 | 1.08 |
Other Unusual Items | 1.68 | 1.68 | 2.22 | 0.76 | 54.81 | 3.34 |
Pretax Income | 3,484 | 3,300 | 2,948 | 2,818 | 1,873 | 556.96 |
Income Tax Expense | 885.28 | 857.74 | 765.26 | 694.02 | 486.73 | 161.28 |
Earnings From Continuing Operations | 2,599 | 2,442 | 2,183 | 2,124 | 1,387 | 395.68 |
Minority Interest in Earnings | -22.64 | -8.03 | -12.86 | -15.43 | -4.07 | 4.5 |
Net Income | 2,576 | 2,434 | 2,170 | 2,108 | 1,383 | 400.18 |
Preferred Dividends & Other Adjustments | - | - | - | - | 4.56 | - |
Net Income to Common | 2,576 | 2,434 | 2,170 | 2,108 | 1,378 | 400.18 |
Net Income Growth | 8.21% | 12.18% | 2.93% | 52.48% | 245.51% | -28.19% |
Shares Outstanding (Basic) | 102 | 102 | 102 | 101 | 93 | 92 |
Shares Outstanding (Diluted) | 102 | 102 | 102 | 101 | 96 | 94 |
Shares Change (YoY) | -0.04% | -0.04% | 0.80% | 5.49% | 1.67% | - |
EPS (Basic) | 25.36 | 23.97 | 21.38 | 20.89 | 14.75 | 4.36 |
EPS (Diluted) | 25.23 | 23.84 | 21.38 | 20.89 | 14.45 | 4.25 |
EPS Growth | 7.60% | 11.51% | 2.37% | 44.56% | 239.82% | -28.19% |
Free Cash Flow | - | 2,500 | -321.75 | 1,875 | 1,615 | 666.11 |
Free Cash Flow Per Share | - | 24.58 | -3.16 | 18.57 | 16.88 | 7.08 |
Dividend Per Share | - | 3.000 | 3.000 | 3.000 | 2.000 | 1.000 |
Dividend Growth | - | - | - | 50.00% | 100.00% | -33.33% |
Gross Margin | 70.58% | 71.37% | 71.76% | 71.88% | 66.14% | 65.30% |
Operating Margin | 22.96% | 23.19% | 24.65% | 26.35% | 22.77% | 13.77% |
Profit Margin | 15.97% | 16.06% | 16.73% | 17.96% | 14.15% | 6.16% |
Free Cash Flow Margin | - | 16.49% | -2.48% | 15.98% | 16.59% | 10.25% |
EBITDA | 4,683 | 4,374 | 3,897 | 3,650 | 2,731 | 1,346 |
EBITDA Margin | 29.03% | 28.86% | 30.05% | 31.11% | 28.05% | 20.70% |
D&A For EBITDA | 979.16 | 859.84 | 700.75 | 558.12 | 514.42 | 450.71 |
EBIT | 3,704 | 3,515 | 3,197 | 3,092 | 2,217 | 894.96 |
EBIT Margin | 22.96% | 23.19% | 24.65% | 26.35% | 22.77% | 13.77% |
Effective Tax Rate | 25.41% | 25.99% | 25.96% | 24.63% | 25.98% | 28.96% |
Revenue as Reported | 16,665 | 15,669 | 13,340 | 12,044 | 9,927 | 6,603 |
Advertising Expenses | - | 309.44 | 290.24 | 272.9 | 215.1 | 90.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.